Skip to main content
NIH funding notice PAR-18-100

Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)

Closed on April 4, 2018.

Posted
November 15, 2017
Close date
April 4, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $273,584 in first-year total cost, median $273,584.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 DKUS-L (55)]1

Most frequent institutions

  1. BOSTON MEDICAL CENTER1
Competing awards under PAR-18-100 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Metabolomics and Renal Functional Reserve1R21DK119751-01WAIKAR, SUSHRUT S.BOSTON MEDICAL CENTER, MA$273,584ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-100: Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) | ScienceDex | ConductScience